FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shouichi Fujimoto

Research Profile

Chemicals & Drugs

Procedures

Renal Dialysis

Anatomy

Disorders

Concepts & Ideas

Physiology

Disease Progression

Geographic Areas

Japan

Co-author Network

Publications

TOP 3
Keiko Nishi; Osamu Ogawa; Shouichi Fujimoto; Shuichi Hisanaga; Kazuo Kitamura
Electrocardiographic assessment of incident atrial fibrillation in hemodialysis patients.
Takashi Iwakiri; Kazuomi Kario; Kazuo Kitamura; Kousuke Marutsuka; Yuichiro Sato; Yuichiro Yano; Shouichi Fujimoto; Kinta Hatakeyama; Yujiro Asada
Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: findings from autopsy analysis.
Tatsunori Toida; Kazuhiro Yamada; Yuji Sato; Susumu Chiyotanda; Shouichi Fujimoto; Keiichi Fukudome; Kazuo Kitamura
Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shouichi Fujimoto (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Keiko Nishi; Osamu Ogawa; Shouichi Fujimoto; Shuichi Hisanaga; Kazuo Kitamura
Electrocardiographic assessment of incident atrial fibrillation in hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2013;17(1):16-23.
2012: Takashi Iwakiri; Kazuomi Kario; Kazuo Kitamura; Kousuke Marutsuka; Yuichiro Sato; Yuichiro Yano; Shouichi Fujimoto; Kinta Hatakeyama; Yujiro Asada
Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: findings from autopsy analysis.
Atherosclerosis 2012;225(2):359-62.
2012: Tatsunori Toida; Kazuhiro Yamada; Yuji Sato; Susumu Chiyotanda; Shouichi Fujimoto; Keiichi Fukudome; Kazuo Kitamura
Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
Clinical nephrology 2012;78(3):216-23.
2012: Keiichi Fukudome; Shouichi Fujimoto; Yuji Sato; Kazuo Kitamura
Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
Nephrology (Carlton, Vic.) 2012;17(3):263-8.
2012: Hiroyuki Komatsu; Yuji Sato; Shouichi Fujimoto; Masao Kikuchi; Kazuo Kitamura
Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
Renal failure 2012;34(4):448-53.
2011: Shouichi Fujimoto; Hiroshi Hashimoto; David R W Jayne; Shigeto Kobayashi; David G I Scott; Kazuo Suzuki; Richard A Watts; Hiroyuki Nunoi
Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.
Rheumatology (Oxford, England) 2011;50(10):1916-20.
2011: Hiroyuki Komatsu; Shouichi Fujimoto
Tonsillectomy combined with steroid pulse therapy induces clinical remission of IgA nephropathy.
Advances in oto-rhino-laryngology 2011;72():57-9.
2011: Keiko Nishi; Takuroh Imamura; Kazuo Kitamura; Tsuneo Ogawa; Shouichi Fujimoto; Yousuke Kakitsubata; Tadashi Ishikawa; Yujiro Asada; Tatsuhiko Kodama
Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Renal failure 2011;33(4):398-404.
2010: Akihiro Fukuda; Shouichi Fujimoto; Shuji Iwatsubo; Hiroshi Kawachi; Kazuo Kitamura
Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Nephrology (Carlton, Vic.) 2010;15(3):321-6.
2009: Ryosuke Nishiura; Shouichi Fujimoto; Yuji Sato; Kazuhiro Yamada; Shuichi Hisanaga; Seiichiro Hara; Hiroyuki Nakao; Kazuo Kitamura
Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients.
American journal of nephrology 2009;29(3):257-63.
2008: Ryosuke Nishiura; Toshihiro Kita; Kazuhiro Yamada; Hiroyuki Komatsu; Seiichiro Hara; Yuji Sato; Shouichi Fujimoto
Radial augmentation index is related to cardiovascular risk in hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12(2):157-63.
2007: Kazuhiro Yamada; Shouichi Fujimoto; Ryosuke Nishiura; Hiroyuki Komatsu; Mariko Tatsumoto; Yuji Sato; Seiichiro Hara; Shuichi Hisanaga; Hideyuki Ochiai; Hiroyuki Nakao; Tanenao Eto
Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(7):2032-7.
2007: Shigehiro Uezono; Yuji Sato; Seiichiro Hara; Shuichi Hisanaga; Keiichi Fukudome; Shouichi Fujimoto; Hiroyuki Nakao; Kazuo Kitamura; Shigeto Kobayashi; Kazuo Suzuki; Hiroshi Hashimoto; Hiroyuki Nunoi
Outcome of ANCA-associated primary renal vasculitis in Miyazaki Prefecture.
Internal medicine (Tokyo, Japan) 2007;46(12):815-22.
2006: Shouichi Fujimoto; Shigehiro Uezono; Shuichi Hisanaga; Keiichi Fukudome; Shigeto Kobayashi; Kazuo Suzuki; Hiroshi Hashimoto; Hiroyuki Nakao; Hiroyuki Nunoi
Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(5):1016-22.
2006: Akihiro Fukuda; Yuji Sato; Shuji Iwatsubo; Akiko Baba; Mariko Tatsumoto; Ryosuke Nishiura; Kazuhiro Yamada; Seiichiro Hara; Shouichi Fujimoto; Tanenao Eto
[Elderly male patient with central nervous system lupus undergoing hemodialysis].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2006;95(6):1109-11.
2006: Shinya Ashizuka; Ryosuke Nishiura; Naoto Ishikawa; Junichi Yamaga; Haruhiko Inatsu; Shouichi Fujimoto; Tanenao Eto
Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(1):54-8.
2006: Shigehiro Uezono; Seiichiro Hara; Yuji Sato; Hiroyuki Komatsu; Naoko Ikeda; Yoshiya Shimao; Tohru Hayashi; Yujiro Asada; Shouichi Fujimoto; Tanenao Eto
Renal biopsy in elderly patients: a clinicopathological analysis.
Renal failure 2006;28(7):549-55.
2006: Shuji Iwatsubo; Shouichi Fujimoto; Michitaka Matsumoto; Yuji Sato; Seiichiro Hara; Kazuo Kitamura; Tanenao Eto
Increased production of adrenomedullin in glomeruli from anti-glomerular basement membrane glomerulonephritis rats treated with methylprednisolone.
Nephron. Experimental nephrology 2006;104(1):e41-7.
2005: Hiroyuki Komatsu; Shouichi Fujimoto; Yuji Sato; Seiichiro Hara; Kazuhiro Yamada; Satoshi Morita; Tanenao Eto
"Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Journal of nephrology 2005;18(6):690-5.
2005: Masao Kikuchi; Shouichi Fujimoto; Hiroko Fukae; Hiroshi Kinoshita; Toshihiro Kita; Masamitsu Nakazato; Tanenao Eto
Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
Journal of the American Society of Nephrology : JASN 2005;16(2):392-7.
2005: Akiko Baba; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Shouichi Fujimoto; Tanenao Eto
[Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjögren's syndrome].
Nihon Jinzo Gakkai shi 2005;47(8):882-6.
2005: Kazuhiro Yamada; Shouichi Fujimoto; Takeshi Tokura; Keiichi Fukudome; Hideyuki Ochiai; Hiroyuki Komatsu; Yuji Sato; Seiichiro Hara; Tanenao Eto
Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients.
Renal failure 2005;27(4):361-5.
2005: Hiroyuki Komatsu; Shouichi Fujimoto; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Tanenao Eto; Hiroyuki Nakao
Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Renal failure 2005;27(1):45-52.
2004: Michitaka Matsumoto; Shouichi Fujimoto; Shuji Iwatsubo; Yuji Sato; Seiichiro Hara; Kazuo Kitamura; Tanenao Eto
Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis.
Clinical and experimental nephrology 2004;8(4):316-21.
2004: Hiroyuki Komatsu; Shouichi Fujimoto; Seiichiro Hara; Yuji Sato; Kazuhiro Yamada; Tanenao Eto
Relationship between serum IgA/C3 ratio and progression of IgA nephropathy.
Internal medicine (Tokyo, Japan) 2004;43(11):1023-8.
2004: Yuji Sato; Seiichiro Hara; Shouichi Fujimoto; Kazuhiro Yamada; Hisashi Sakamaki; Tanenao Eto
Minimal change nephrotic syndrome after allogenic hematopoietic stem cell transplantation.
Internal medicine (Tokyo, Japan) 2004;43(6):512-5.
2004: Shouichi Fujimoto; Tanenao Eto
[Adrenomedullin].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():206-10.
2004: Shouichi Fujimoto; Seiichirou Hara; Yuji Sato; Kazuhiro Yamada; Shuichi Hisanaga; Tanenao Eto
Nephrotic syndrome caused by membranous nephropathy: response to a short course of cyclophosphamide alternating with prednisolone.
Internal medicine (Tokyo, Japan) 2004;43(1):30-4.
2003: Takeshi Tokura; Hiroshi Kinoshita; Shouichi Fujimoto; Kazuo Kitamura; Tanenao Eto
Plasma levels of proadrenomedullin N-terminal 20 peptide and adrenomedullin in patients undergoing hemodialysis.
Nephron. Clinical practice 2003;95(2):c67-72.
2003: Hiroyuki Komatsu; Seiichiro Hara; Masao Kikuchi; Michitaka Matsumoto; Kazuhiro Yamada; Yuji Sato; Shouichi Fujimoto; Tanenao Eto
[Two cases of interstitial nephritis with primary Sjögren's syndrome successfully treated by steroid therapy].
Nihon Jinzo Gakkai shi 2003;45(4):398-404.
2003: Yuji Sato; Shouichi Fujimoto; Kazuhiro Yamada; Seiichiro Hara; Tanenao Eto
[Analysis of factors affecting the course of renal disease progression in patients with established renal insufficiency].
Nihon Jinzo Gakkai shi 2003;45(4):372-7.
2002: Seiichiro Hara; Yujiro Asada; Shouichi Fujimoto; Kousuke Marutsuka; Kinta Hatakeyama; Akinobu Sumiyoshi; Tanenao Eto
Atheroembolic renal disease: clinical findings of 11 cases.
Journal of atherosclerosis and thrombosis 2002;9(6):288-91.
2001: Hiroshi Kinoshita; Shouichi Fujimoto; Takeshi Tokura; Shuichi Hisanaga; Kazuo Kitamura; Tanenao Eto
Plasma mature form of adrenomedullin in diabetic nephropathy.
Internal medicine (Tokyo, Japan) 2001;40(8):841-2.
2001: Takeshi Tokura; Hiroshi Kinoshita; Shouichi Fujimoto; Shuichi Hisanaga; Kazuo Kitamura; Tanenao Eto
Plasma levels of mature form of adrenomedullin in patients with haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(4):783-6.
2001: Hiroshi Kinoshita; Shigehiro Uezono; Keiichi Fukudome; N Yokota; Shuichi Hisanaga; Shouichi Fujimoto; Tanenao Eto
Serum remnant lipoprotein levels in nephrotic syndrome.
Clinical nephrology 2001;55(3):263-4.
2001: Keiichi Fukudome; Shouichi Fujimoto; Yuji Sato; Shuichi Hisanaga; Tanenao Eto
Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients.
Nephron 2001;87(1):35-41.
2000: Hiroshi Kinoshita; Shouichi Fujimoto; Kazuo Kitamura; Y Matsuura; Shigehiro Uezono; Shuichi Hisanaga; Tanenao Eto
Increased plasma levels of mature adrenomedullin in chronic glomerulonephritis.
Nephron 2000;86(3):333-8.
1999: T Ishihara; N Yokota; Shuichi Hisanaga; Shouichi Fujimoto; N Hirayama; Johji Kato; Kazuo Kitamura; Tanenao Eto
Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
Clinical nephrology 1999;52(2):119-23.
1999: Hiroshi Kinoshita; Shouichi Fujimoto; Kazuo Kitamura; N Yokota; M Kawamoto; Takeshi Tokura; Shuichi Hisanaga; Tanenao Eto
Plasma and urine levels of adrenomedullin and proadrenomedullin N-terminal 20 peptide in chronic glomerulonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(1):114-9.
1999: Shuichi Hisanaga; N Ueno; H Inagaki; Takeshi Tokura; Shigehiro Uezono; N Yokota; Shouichi Fujimoto; Tanenao Eto
[Exercise-induced acute renal failure associated with renal vasoconstriction].
Nihon Jinzo Gakkai shi 1999;41(4):406-12.
1998: Hiroshi Kinoshita; Shouichi Fujimoto; N Yokota; Hideyuki Ochiai; Shuichi Hisanaga; Seiichiro Hara; Akinobu Sumiyoshi; Tanenao Eto
An isolated case of nephronophthisis: medullary cystic disease without typical onset.
Internal medicine (Tokyo, Japan) 1998;37(1):83-5.
1998: Yuji Sato; Shouichi Fujimoto; K Hamai; Tanenao Eto
Serial alterations of glomerular matrix-degrading metalloproteinase activity in anti-thymocyte-induced glomerulonephritis in rats.
Nephron 1998;78(2):195-200.
1997: Hiroshi Kinoshita; Shouichi Fujimoto; Masamitsu Nakazato; N Yokota; Y Date; H Yamaguchi; Shuichi Hisanaga; Tanenao Eto
Urine and plasma levels of uroguanylin and its molecular forms in renal diseases.
Kidney international 1997;52(4):1028-34.
1997: T Ishihara; Johji Kato; Kazuo Kitamura; F Katoh; Shouichi Fujimoto; Kenji Kangawa; Tanenao Eto
Production of adrenomedullin in human vascular endothelial cells.
Life sciences 1997;60(20):1763-9.
1997: Hiroshi Kinoshita; Masamitsu Nakazato; H Yamaguchi; S Matsukura; Shouichi Fujimoto; Tanenao Eto
Increased plasma guanylin levels in patients with impaired renal function.
Clinical nephrology 1997;47(1):28-32.
1995: Y Sato; Shouichi Fujimoto; K Mishima; Y Yamamoto; Tanenao Eto
Kidney-limited recurrence in a patient with microscopic polyarteritis.
Internal medicine (Tokyo, Japan) 1995;34(10):1000-4.
1992: Shouichi Fujimoto; N Hirayama; T Uchida; F Iemura; Y Yamamoto; Tanenao Eto; H Washimine; Akinobu Sumiyoshi
Horseshoe kidney and membranous glomerulonephritis with cold activation of complement.
Internal medicine (Tokyo, Japan) 1992;31(5):625-8.
1991: Shouichi Fujimoto; Y Yamamoto; Shuichi Hisanaga; S Morita; Tanenao Eto; K Tanaka
Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;17(6):687-92.
1991: Shouichi Fujimoto; Y Yamamoto; J Miyata; S Morita; S Hisanaga; K Tanaka; A Sumiyoshi; M Koono
[Clinicopathologic study of adult-onset membranoproliferative glomerulonephritis].
Nihon Jinzo Gakkai shi 1991;33(2):145-51.
1990: Shouichi Fujimoto; Y Yamamoto; M Saita; S Hisanaga; S Morita; K Tanaka; A Sumiyoshi; M Koono
[Renal failure associated with polyarteritis nodosa].
Nihon Jinzo Gakkai shi 1990;32(6):739-44.
1990: Shuichi Hisanaga; H Kawagoe; Y Yamamoto; N Kuroki; Shouichi Fujimoto; K Tanaka; M Kurokawa
Nephrotic syndrome associated with recombinant interleukin-2.
Nephron 1990;54(3):277-8.
1990: Shouichi Fujimoto; H Kondoh; Y Yamamoto; Shuichi Hisanaga; K Tanaka
Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy.
American journal of nephrology 1990;10(3):231-6.